These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23373309)

  • 1. [Pathological interaction between diabetes mellitus and Alzheimer's disease].
    Takeda S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):239-44. PubMed ID: 23373309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
    Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7036-41. PubMed ID: 20231468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroimaging studies of diabetes and risk of Alzheimer's disease].
    Hirano S; Shimada H; Yoshiyama Y
    Brain Nerve; 2012 Dec; 64(12):1411-9. PubMed ID: 23209068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease.
    Zhang Z; Fang P; Shi M; Zhu Y; Bo P
    Mech Ageing Dev; 2015 Sep; 150():20-6. PubMed ID: 26253934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalopathies: the emerging diabetic complications.
    Sima AA
    Acta Diabetol; 2010 Dec; 47(4):279-93. PubMed ID: 20798963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
    Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
    Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease.
    Xu W; Qiu C; Winblad B; Fratiglioni L
    Diabetes; 2007 Jan; 56(1):211-6. PubMed ID: 17192484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.
    Watson GS; Craft S
    Eur J Pharmacol; 2004 Apr; 490(1-3):97-113. PubMed ID: 15094077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
    FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
    Kroner Z
    Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease.
    Zetterberg H; Blennow K
    Alzheimers Dement; 2013 Jul; 9(4):459-62. PubMed ID: 23159047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.